Cited by 330Advanced Drug Delivery SystemsAdvancements in Transdermal Drug DeliveryNanoparticle-Based Drug Delivery

Suprachoroidal drug delivery to the back of the eye using hollow microneedles

Open access
Patel, Samirkumar R., Lin, Angela S. P., Edelhauser, Henry F., Prausnitz, Mark R.·2011·Pharmaceutical Research

Abstract

Purpose In this work, we tested the hypothesis that microneedles provide a minimally invasive method to inject particles into the suprachoroidal space for drug delivery to the back of the eye.Methods A single, hollow microneedle was inserted into the sclera, and infused nanoparticle and microparticle suspensions into the suprachoroidal space. Experiments were performed on whole rabbit, pig, and human eyes ex vivo. Particle delivery was imaged using brightfield and fluorescence microscopy as well as microcomputed tomography.Results Microneedles were shown to deliver sulforhodamine B as well as nanoparticle and microparticle suspensions into the suprachoroidal space of rabbit, pig, and human eyes. Volumes up to 35 μL were administered consistently. Optimization of the delivery device parameters showed that microneedle length, pressure, and particle size played an important role in determining successful delivery into the suprachoroidal space. Needle lengths of 800-1,000 μm and applied pressures of 250-300 kPa provided most reliable delivery.Conclusions Microneedles were shown for the first time to deliver nanoparticle and microparticle suspensions into the suprachoroidal space of rabbit, pig and human eyes. This shows that microneedles may provide a minimally invasive method for controlled drug delivery to the back of the eye.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11095-010-0271-y

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Suprachoroidal injection has been successful in large-animal models and was demonstrated to be a safer approach in a phase 3 clinical trial to treat uveitis with macular edema.

    “This method has been successful in large-animal models and was demonstrated to be a safer approach in a phase 3 clinical trial to treat uveitis with macular edema [20,21].”

    From The Ocular Gene Delivery Landscape (2021) · cites this paper as [20]

  • The suprachoroidal route allows for rapid dissemination of a small amount of agent around most of the eye.

    “Its structural continuity and small volume are important for understanding the potential of the suprachoroidal space as a drug delivery route, which allows for rapid dissemination of a small amount of agent around most of the eye [305].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Patel, S. R., Lin, A. S. P., Edelhauser, H. F., & Prausnitz, M. R.
Affiliations
  • Georgia Institute of Technology (US)
  • Emory University (US)
Corresponding author
  • Edelhauser, Henry F.
  • Prausnitz, Mark R.
Venue
Pharmaceutical Research
Published
2010-09-21
Volume
28
Issue
1
Pages
166-176
ISSN
  • 0724-8741 (ISSN-L)
  • 1573-904X
OpenAlex
W1977812165
Cited by
330
References
27
Citations by year
2026: 21 · 2025: 26 · 2024: 30 · 2023: 24 · 2022: 17 · 2021: 31 · 2020: 26 · 2019: 18 · 2018: 19 · 2017: 22 · 2016: 25 · 2015: 19 · 2014: 14 · 2013: 13 · 2012: 16
FWCI
8.28
Type
journal article
Language
en
Open access
Locations
  • Pharmaceutical Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Eye Institute (R24EY017045)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
hollow microneedles, nanoparticle delivery, microparticle delivery, sclera, sulforhodamine B, injection pressure, needle length, particle size
MeSH terms
Animals, Choroid, Drug Carriers, Pharmaceutical Preparations, Humans, Intraocular Pressure, Microinjections, Microscopy, Fluorescence, Needles, Rabbits, Retina, Sclera, Swine, Drug Delivery Systems, Nanoparticles, Injections, Intraocular, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review